Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Emtricitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Kaposi 1 HIV Infections 1 Acquired Immunodeficiency Syndrome 1

Interventions

Cyclophosphamide 1733 Radiotherapy 1687 Cisplatin 1534 Carboplatin 1301 Gemcitabine 1208 Paclitaxel 1111 Bevacizumab 1083 Docetaxel 1054 pembrolizumab 1043 Capecitabine 993 Oxaliplatin 982 Fluorouracil 919 Dexamethasone 822 Magnetic Resonance Spectroscopy 816 Nivolumab 788 Rituximab 777 Drug Therapy 757 Surveys and Questionnaires 750 Doxorubicin 706 Etoposide 698 Radiosurgery 690 Blood Specimen Collection 677 Irinotecan 653 Cytarabine 630 fludarabine 613 Leucovorin 576 Surgical Procedures, Operative 537 Lenalidomide 525 Radiation 489 Biopsy 486

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00444379 2014-08-20

ARKS

University of California, San Francisco

Phase 4 Completed

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡